Archive - SMC COVID-19 research tracking

Immune evasion, long Covid, multiple infections, infection risks, ventilation

Jun 23

Omicron & immune evasion, nasal vaccine, re-infection rates, public health communications

Jun 16

BA.4 & BA.5, new Moderna booster, Paxlovid, long Covid, new therapies

Jun 9

Comparing vaccines, hybrid immunity, Omicron variants, Paxlovid, mask effectiveness

Jun 2

Long covid, waning immunity, Omicron variants, hepatitis, antiviral therapies

May 26

long covid, hepatitis risks, new therapies and diagnostic tests, estimating health costs

May 19

vaccine comparisons, 4 vaccine doses, new vaccines

May 19

Future vaccine prospects, three vaccine doses, Omicron lineages, long Covid

May 12

Booster vaccine doses, viral and variant evolution, cognitive decline, rapid antigen tests

May 5

Vaccine comparisons, three Pfizer doses, T-cell responses, pan-coronavirus vaccines, long Covid, viral loads, viral evolution

Apr 28

Vaccine effectiveness in children, 3 dose effectiveness in adults, long Covid, monoclonal antibody therapies

Apr 21

Effectiveness of different numbers of vaccine doses, mutations in the virus or people that affect risks, and low risk of severe Covid in young people

Apr 14

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts